A Study of Rapastinel for Rapid Treatment of Depression and Suicidality in Major Depressive Disorder

NCT03352453 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

138

Enrollment

INDUSTRY

Sponsor class

Stopped Study stopped due to business reasons.

Conditions

Depressive Disorder, Major

Interventions

DRUG: Rapastinel
DRUG: Placebo

Sponsor

Naurex, Inc, an affiliate of Allergan plc